About Luminary Therapeutics
Luminary Therapeutics is a private company based in Minneapolis, Minnesota. It has reported $14,502,700 raised in six offerings on Form D since November 2019. Its chief executive is Jeff Liter.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 14, 2025 | Nov 5, 2025 | $1,406,112of $12.3M target | 6 | $234K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 20, 2024 | Jan 8, 2025 | $5,184,500of $5.9M target | 48 | $108K | EquityRule 506(b) | Form D ↗ |
| Sep 28, 2022 | Jan 11, 2023amended Jan 8, 2025 | $5,222,095of $5.5M target | 49 | $106K | Securities on exercise, SAFE (Simple Agreement Future Equity)Rule 506(b) | Form D/A ↗2 earlier filings |
| Oct 26, 2021 | Nov 4, 2021 | $374,993of $1.5M target | 3 | $124K | EquityRule 506(b) | Form D ↗ |
| Jan 12, 2021 | Feb 9, 2021 | $825,000of $1.0M target | 11 | $75,000 | EquityRule 504 | Form D ↗ |
| Oct 29, 2019 | Nov 14, 2019 | $1,490,000fully sold | 11 | $135K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $14,502,700 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Luminary Therapeutics's Form D filed Nov 5, 2025.
BM
Branden Moriarity
Director
MC
Mark Chance
Director
TL
Tracey Lodie
Director
JH
James Haymaker
Director and promoter
JW
John Wells
Director
JR
Jeff Ross
Director
JL
Jeff Liter
President and Chief Executive Officer, director
Earlier filings also listed George Cox (director, last listed Nov 2021) and David Largaespada (executive officer, director and promoter, last listed Nov 2021).